DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+15.22%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$126M
AUM Growth
+$126M
(+8.8%)
Cap. Flow
+$2.44M
Cap. Flow
% of AUM
1.93%
Top 10 Holdings %
Top 10 Hldgs %
41.21%
Holding
111
New
17
Increased
15
Reduced
24
Closed
15
Top Buys
| 1 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$2.83M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$2.52M |
| 3 |
Tandem Diabetes Care
TNDM
|
$2.08M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$1.89M |
| 5 |
Spyre Therapeutics
SYRE
|
$1.7M |
Top Sells
| 1 |
AbbVie
ABBV
|
$2.49M |
| 2 |
BEAT
BioTelemetry, Inc.
BEAT
|
$2.21M |
| 3 |
Masimo
MASI
|
$1.89M |
| 4 |
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
|
$1.37M |
| 5 |
CYAD
Celyad Oncology SA American Depositary Shares
CYAD
|
$1.33M |
Sector Composition
| 1 | Healthcare | 71.01% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXTM
1
DELISTED
NxStage Medical Inc.
NXTM
| $7.73M | 6.13% |
356,509
-40,045
| -10% | -$868K |
|
2
AtriCure
ATRC
$1.8B
| $7.26M | 5.76% |
513,946
+25,500
| +5% | +$360K |
|
|
VTAE
3
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $7.12M | 5.65% |
660,188
-127,185
| -16% | -$1.37M |
|
|
DERM
4
DELISTED
Dermira, Inc.
DERM
| $5.66M | 4.49% |
193,642
+21,761
| +13% | +$637K |
|
|
5
AbbVie
ABBV
$374B
| $4.73M | 3.75% |
76,331
-40,250
| -35% | -$2.49M |
|
|
ALDR
6
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $4.13M | 3.27% |
165,313
+25,000
| +18% | +$624K |
|
7
Rigel Pharmaceuticals
RIGL
$690M
| $4.12M | 3.26% |
1,847,087
-29,405
| -2% | -$65.6K |
|
8
Novavax
NVAX
$1.23B
| $4M | 3.17% |
550,000
-3,500
| -0.6% | -$25.4K |
|
|
CYNA
9
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $3.72M | 2.95% |
222,359
+169,418
| +320% | +$2.83M |
|
10
Galapagos
GLPG
$2.05B
| $3.53M | 2.79% |
63,568
-2,000
| -3% | -$111K |
|
11
Neurocrine Biosciences
NBIX
$14.1B
| $3.43M | 2.72% |
75,503
-797
| -1% | -$36.2K |
|
|
AERI
12
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.83M | 2.24% |
160,869
-18,900
| -11% | -$333K |
|
13
Insulet
PODD
$24.3B
| $2.79M | 2.21% |
92,164
-13,854
| -13% | -$419K |
|
|
TSRO
14
DELISTED
TESARO, Inc.
TSRO
| $2.52M | 2% |
+30,000
| New | +$2.52M |
|
|
LOXO
15
DELISTED
Loxo Oncology, Inc
LOXO
| $2.36M | 1.87% |
101,966
+62,966
| +161% | +$1.46M |
|
|
AGTC
16
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.36M | 1.87% |
167,192
| – | – |
|
|
17
Tandem Diabetes Care
TNDM
$864M
| $2.36M | 1.87% |
312,756
+276,205
| +756% | +$2.08M |
|
|
IMMU
18
DELISTED
Immunomedics Inc
IMMU
| $1.89M | 1.5% |
+815,000
| New | +$1.89M |
|
|
ACHN
19
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $1.85M | 1.46% |
236,500
| – | – |
|
|
20
Spyre Therapeutics
SYRE
$1B
| $1.7M | 1.35% |
+350,392
| New | +$1.7M |
|
|
BEAT
21
DELISTED
BioTelemetry, Inc.
BEAT
| $1.63M | 1.29% |
100,000
-135,645
| -58% | -$2.21M |
|
|
ZGNX
22
DELISTED
Zogenix, Inc.
ZGNX
| $1.59M | 1.26% |
197,538
+118,138
| +149% | +$951K |
|
|
BSTC
23
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.59M | 1.26% |
39,704
| – | – |
|
24
iShares Biotechnology ETF
IBB
$5.69B
| $1.54M | 1.22% |
6,000
| – | – |
|
|
SPNC
25
DELISTED
Spectranetics Corp
SPNC
| $1.49M | 1.18% |
79,812
| – | – |
|